Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTandem Group Regulatory News (TND)

Share Price Information for Tandem Group (TND)

Share Price is delayed by 15 minutes
Get Live Data
173.50    1.00 (0.58%)
Bid:
170.00
Ask:
177.00
Spread: 7.00 (4.118%)
Market Cap: £9.57m
TND Live PriceLast checked at - London Stock Exchange

Intraday Tandem Group Share Chart

AGM Trading Statement

24 Jun 2025 07:00

RNS Number : 0594O
Tandem Group PLC
24 June 2025
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

24 June 2025

Tandem Group plc

(the 'Group' or the 'Company')

AGM Trading Statement

 

Tandem Group plc (AIM: TND), designers, developers, distributors and retailers of sports, leisure and mobility equipment, announces that at the Annual General Meeting of the Company to be held today at 11.00 am the Company's Chairman, Steve Grant, will make the following statement:

We are pleased to report that Tandem remains on track to meet market expectations for the financial year ending 31 December 2025.

At 31 May 2025, our Group sales position overall is ahead of the prior year by 15% and we have been focussing heavily on introducing newness to our product range, ensuring that our offerings align with current trends and maintain a high level of innovation.

With the UK enjoying record sunshine this spring, favourable weather has provided a welcome boost for our seasonally dependent products. However, we continue to operate in what remains a challenging environment shaped by ongoing inflationary pressures, rising employment costs and fluctuating consumer confidence. Despite this backdrop, the Group's resilience, and our focus on execution, positions us well for the remainder of the current year and beyond.

In our Toys, Sports, and Leisure division we are currently tracking 6% behind the same period last year. This is in line with Board expectations due to the shift in phasing towards the second half of the year, where we anticipate stronger FOB results. Looking ahead to the rest of 2025, we have a robust pipeline of brands and licenses planned.

Our Bikes division has delivered impressive growth, outperforming the market across each of the pedal, electric, and junior categories. Sales are up 52% year to date. Our newness and innovation across all categories have been instrumental in driving an excellent performance year to date.

We are looking forward to the upcoming launch of the new HOY children's bike range, developed in collaboration with cycling legend Sir Chris Hoy. This exciting new range, consisting of eight models, is set to launch in early September 2025, with dealers already placing an encouraging level of pre-orders.

In the Golf division, there has been a change in our sales pattern versus last year. Sales year to date are 6% behind the same period last year. This is mainly due to our Freight-On-Board (FOB) order phasing which has transitioned towards summer, driven by the introduction of our new 2025 range and is therefore again in line with Board expectations.

Our Home and Garden division has seen a sales increase of 14%, with growth supported by the introduction of new categories including outdoor heating, outdoor rugs, internal storage, home décor and the driest spring in over a century, which has positively impacted demand. Looking ahead to the second half of the year, this division will also launch additional innovative and on-trend products to further strengthen our offering.

 

Group Outlook

Refreshment and elevation of the Group's product range is a continuous process that remains essential to the Company's long-term success. We have continued to keep tight control of our costs, whilst developing new sales channels and forging new relationships with customers.

Conditions remain challenging but we are working closely with our European and Asian suppliers to improve our competitiveness and introducing more innovation across our ranges.

With our improved product range and cost control enabling keen pricing, we are looking to grow our sales to new UK customers. The Group also now has dedicated resource to grow sales into Europe.

In summary, the Board remains confident in Tandem's ability to meet market expectations for the current year. We are focussed on improving returns and on recommencing the payment of dividends as soon as trading performance and cashflow permits.

 

 Enquiries:

Tandem Group plc

Peter Kimberley, Chief Executive

Gurvinder Kaur, Company Secretary

Telephone 0121 748 8000

 

Nominated Adviser

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Ben Jeynes / Callum Davidson - Corporate Finance

Michael Johnson / Jamie Anderson - Sales and Equity Capital Markets

Telephone 020 7220 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDXLFLEQLFBBZ
Date   Source Headline
17th Nov 20223:29 pmRNSPDMR Transactions
16th Nov 20224:36 pmRNSDirector Dealing and Total Voting Rights
14th Nov 20223:54 pmRNSDirector/PDMR Shareholding
31st Oct 20223:45 pmRNSDirector Dealing and Total Voting Rights
4th Oct 20223:29 pmRNSExercise of Options and Total Voting Rights
4th Oct 20227:00 amRNSDirectorate Change
15th Sep 20227:00 amRNSHalf Yearly Report
23rd Aug 20224:27 pmRNSHolding(s) in Company
23rd Jun 20225:10 pmRNSResult of AGM
23rd Jun 20227:00 amRNSAGM Statement
1st Jun 20227:00 amRNSTotal Voting Rights
19th May 20227:00 amRNSDirectorate Change and Total Voting Rights
28th Apr 20222:08 pmRNSDirector Dealing and Total Voting Rights
27th Apr 20227:00 amRNSDirectorate Change
6th Apr 20225:24 pmRNSDirector Dealing and Total Voting Rights
28th Mar 20227:00 amRNSFinal Results
1st Mar 202210:09 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change, Director/PDMR Share Dealing
1st Feb 202211:33 amRNSTotal Voting Rights
31st Jan 20227:00 amRNSTrading Update and Notice of Results
24th Jan 20221:06 pmRNSDirector Dealing and Total Voting Rights
16th Dec 20211:31 pmRNSHolding(s) in Company
7th Dec 20217:00 amRNSTrading Update
8th Nov 20217:00 amRNSDirectorate Change
30th Sep 202110:13 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSHalf Yearly Report
31st Aug 20214:51 pmRNSTotal Voting Rights
28th Jun 20217:00 amRNSChange of Adviser
25th Jun 20217:00 amRNSResult of AGM
24th Jun 20217:00 amRNSAGM Statement
21st Jun 20217:00 amRNSAGM Arrangements
11th Jun 202112:57 pmRNSDirector/PDMR Shareholding
2nd Jun 20212:09 pmRNSTotal Voting Rights
2nd Jun 20217:00 amRNSTrading Update, AGM arrangements and Board Change
29th Apr 20217:00 amRNSGrant of Share Options
23rd Apr 20212:12 pmRNSHolding(s) in Company
23rd Apr 20212:09 pmRNSExercise of Options and Directors’ Shareholdings
31st Mar 20213:45 pmRNSTotal Voting Rights
29th Mar 20215:53 pmRNSDirector/PDMR Shareholding
25th Mar 20217:01 amRNSExercise of Options and Directors’ Shareholdings
25th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSAcquisition of freehold land
9th Feb 202110:32 amRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update and Notice of Results
31st Dec 20201:14 pmRNSHolding(s) in Company
31st Dec 20207:00 amRNSTotal Voting Rights
23rd Dec 20205:37 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSHolding(s) in Company
21st Oct 202012:41 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.